Mark Identification

QTC

Serial Number

75582112

Filing Date

Nov 3, 1998

Registration Date

May 21, 2002

Trademark by

XENOVA LTD.

Classification Information

Chemicals for use in the manufacture of pharmaceutical products; chemical preparations for use in manufacture of pharmaceuticals; microbial and plant extracts used as ingredients in drugs

Chemicals

Pharmaceutical and veterinary preparations and substances, namely ointments, creams, gels, impregnated patches, topically applied pharmaceuticals, orally administered preparations namely tablets, capsules, syrups, suspensions, and emulsions for the treatment of human pharmaceutical indications namely cancer, cardiovascular, respiratory, autoimmunity, infectious and neurological diseases; parenteral products, namely solutions, freeze dried preparations and emulsions, for injection or infusion for the treatment of human pharmaceutical indications, namely cancer, cardiovascular, respiratory, autoimmunity, infectious and neurological diseases; aerosols, powders and products to be inhaled for the treatment of human pharmaceutical indications, namely cancer, cardiovascular, respiratory autoimmunity, infectious and neurological diseases; suppositories, pessaries, products using lipid encapsulation for the treatment of human pharmaceutical indications, namely cancer, cardiovascular, respiratory, autoimmunity, infectious and neurological diseases; combinations with other molecules to increase the bioavailability of non-systematically available drugs, namely antibiotics and anticancers; fungicides for agricultural and domestic use; herbicides for agricultural and domestic use; pesticides for agricultural and domestic use

Pharmaceuticals

Research and development services for others for new chemical, biochemical and biological products; research and development services for others for the improvement of existing products; chemical consultation, namely the development of assay systems in the development of libraries of natural products and chemicals; chemicals; chemical analysis of natural products exemplified by microbial and plant extracts; research services relating to the development of new drugs; provision or lending of microbials, plant extracts and chemical samples; providing databases containing information regarding a library of compounds produced as a result of screening purified chemical entities derived from microbes and plants; consultancy in the field of the screening and analysis of data resulting from the testing of natural products libraries; technical research in the field of the discovery and development of pharmaceutical products using a library of compounds produced as a result of biologically screening purified chemical entities derived from microbes and plants; testing of purified chemical entities derived from microbes and plants

Computer and Scientific